Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/EISAI-CO-LTD-6492461/news/Eisai-Satisfies-All-case-Study-Requirement-for-Antiepileptic-Agent-Inovelon-42176006/?utm_source=whatsapp&utm_medium=social&utm_campaign=share